ctrl K

NLS Pharmaceutics AG (NLSP)

NASDAQ: NLSP · Real-Time Price · USD

1.58

0.08 (5.33%)

At close: May 02, 2025, 3:48 PM

1.59

0.49%

After-hours: May 02, 2025, 04:13 PM EDT

NLS Pharmaceutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	11.41K	11.41K	10.05K	n/a	n/a	n/a	n/a
Gross Profit	-11.41K	-11.41K	-10.05K	n/a	n/a	n/a	n/a
Operating Income	-11.81M	-15.48M	-11.86M	-2.3M	-4.2M	-3.45K	-5.77M
Interest Income	n/a	100.87	68.13	233.70	819.71	n/a	890.40
Pretax Income	-12.17M	-16.5M	-11.95M	-2.86M	-5.45M	-5.15K	-6.66M
Net Income	-12.17M	-16.5M	-11.95M	-2.86M	-5.45M	-5.15K	-6.66M
Selling & General & Admin	5.9M	6.49M	5.93M	2.2M	2.49M	2.74K	1.44M
Research & Development	5.91M	8.98M	5.92M	99.58K	1.7M	708.45	4.32M
Other Expenses	0.00	10.04K	-17.32K	-328.37K	n/a	n/a	n/a
Operating Expenses	11.81M	15.47M	11.85M	2.3M	4.2M	3.45K	5.77M
Interest Expense	145.15K	100.87K	68.13K	233.7K	819.71K	n/a	890.4K
Selling & Marketing Expenses	n/a	6.49M	5.93M	2.2M	2.49M	n/a	n/a
Cost & Expenses	11.81M	15.48M	11.86M	2.3M	4.2M	3.45K	5.77M
Income Tax Expense	n/a	2.00	-226.51K	-2.3K	-4.2K	n/a	-5.77K
Shares Outstanding (Basic)	38.18M	19.68M	14.75M	4.82M	11.14M	156.00	11.78M
Shares Outstanding (Diluted)	38.18M	19.68M	14.75M	4.82M	11.14M	156.00	11.78M
EPS (Basic)	-0.32	-0.84	-0.81	-0.59	-0.49	-32.99	-0.57
EPS (Diluted)	-0.32	-0.84	-0.81	-0.59	-0.49	-32.99	-0.57
EBITDA	-11.8M	-15.47M	-11.85M	n/a	-430.4K	n/a	-5.77M
EBIT	-11.81M	-15.48M	-11.88M	-2.63M	-4.63M	-3.45K	-5.77M
Depreciation & Amortization	11.41K	11.41K	10.05K	2.3M	4.2M	3.45K	5.77M